Aptorum files amended 8-K updating DiamiR Biosciences financial statements
NIKI•Merger closing and name change
The filing also described the July 20, 2026 closing of Aptorum’s merger with DiamiR and Aptorum’s domestication and name change to Niki BioSolutions.
Assets, liabilities and net loss
DiamiR reported total assets of $618,078 at May 31, 2026, versus total liabilities of $2.21 million.
DiamiR posted a net loss of $659,936 for the year ended May 31, 2026, versus $743,235 a year earlier.
Audit raises going-concern doubt
The audit report flagged substantial doubt about DiamiR’s ability to continue as a going concern, citing a significant working capital deficiency and ongoing operating losses.
Amended filing updates DiamiR financial statements
Aptorum filed an amended current report that restated its disclosure to include DiamiR Biosciences’ audited consolidated financial statements for the years ended May 31, 2026 and May 31, 2025.
